Von Willebrand factor propeptide in vascular disorders

被引:0
作者
van Mourik, JA
de Wit, TR
机构
[1] CLB, Dept Plasma Prot & Blood Coagual, NL-1066 CX Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
关键词
Von Willebrand factor; endothelial cells; von Willebrand factor propeptide; vascular disease; Weibel-Palade bodies;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Von Willebrand factor (VWF) is a multifunctional plasma protein that plays a prominent role in haemostasis. In endothelial cells, processing of its precursor pro-VWF results in the formation of two large polypeptides, mature VWF and a propeptide. These proteins are co-secreted on an equimolar basis but are cleared from the circulation at different rates. VWF levels are frequently elevated in response to vascular disorders. Similarly, propeptide levels are increased under these conditions, although primarily in fulminant vascular disease, such as thrombotic thrombocytopenic purpura and septicemia. In chronic vascular disease, e.g. diabetes or peripheral vascular disease, propeptide levels are much less elevated. The differential response of VWF and propeptide levels to vascular disease could provide a means to assess the extent and time course of endothelial cell activation. After secretion, the propeptide may play a role in modulating cellular adhesion processes. Thus, enhanced propeptide secretion seems not to be of merely diagnostic significance.
引用
收藏
页码:164 / 171
页数:8
相关论文
共 77 条
[1]   Platelets adhere to and translocate on von Willebrand factor presented by endothelium in simulated veins [J].
André, P ;
Denis, CV ;
Ware, J ;
Saffaripour, S ;
Hynes, RO ;
Ruggeri, ZM ;
Wagner, DD .
BLOOD, 2000, 96 (10) :3322-3328
[2]   CALCIUM CALMODULIN TRANSDUCES THROMBIN-STIMULATED SECRETION - STUDIES IN INTACT AND MINIMALLY PERMEABILIZED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS [J].
BIRCH, KA ;
POBER, JS ;
ZAVOICO, GB ;
MEANS, AR ;
EWENSTEIN, BM .
JOURNAL OF CELL BIOLOGY, 1992, 118 (06) :1501-1510
[3]  
Blann AD, 1997, THROMB HAEMOSTASIS, V77, P1077
[4]   Circulating von Willebrand factor antigen II in atherosclerosis: a comparison with von Willebrand factor and soluble thrombomodulin [J].
Blann, AD ;
de Romeuf, C ;
Mazurier, C ;
McCollum, CN .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (03) :261-266
[5]  
BONFANTI R, 1989, BLOOD, V73, P1109
[6]   STRUCTURE OF PRE-PRO-VON WILLEBRAND FACTOR AND ITS EXPRESSION IN HETEROLOGOUS CELLS [J].
BONTHRON, DT ;
HANDIN, RI ;
KAUFMAN, RJ ;
WASLEY, LC ;
ORR, EC ;
MITSOCK, LM ;
EWENSTEIN, B ;
LOSCALZO, J ;
GINSBURG, D ;
ORKIN, SH .
NATURE, 1986, 324 (6094) :270-273
[7]   Quantitative analysis of von Willebrand factor propeptide release in vivo: Effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans [J].
Borchiellini, A ;
Fijnvandraat, K ;
tenCate, JW ;
Pajkrt, D ;
vanDeventer, SJH ;
Pasterkamp, G ;
MeijerHuizinga, F ;
ZwartHuinink, L ;
Voorberg, J ;
vanMourik, JA .
BLOOD, 1996, 88 (08) :2951-2958
[8]  
de Romeuf C, 1998, THROMB HAEMOSTASIS, V80, P37
[9]  
deJong SC, 1997, THROMB HAEMOSTASIS, V78, P1332
[10]  
DELEEUW HP, 2000, THESIS U AMSTERDAM